ÂÜÀòÂÒÂ×

David Hay has a rich background in academia and research, holding various positions such as Chair of Tissue Engineering at the University of Edinburgh, Professor at Zhejiang University, and Founder, Chairman, and CEO of Stimuliver. David has also co-founded Stemnovate and HigherSteaks, contributing to innovative technologies in drug screening and cell culture. With a PhD in Molecular and Cellular Biology from the University of St Andrews, David Hay has made significant contributions to fields such as stem cell biology and tissue engineering.